|
HS Code |
147946 |
| Iupac Name | 1H-pyrrolo[3,4-b]pyridine-5,7(2H,6H)-dione, tetrahydro-6-(phenylmethyl)- |
| Molecular Formula | C14H14N2O2 |
| Molecular Weight | 242.28 g/mol |
| Cas Number | 99464-64-9 |
| Structural Class | Benzyl-substituted tetrahydropyrrolopyridinedione |
| Appearance | Off-white to pale yellow solid |
| Melting Point | 189-193°C |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Boiling Point | Decomposes before boiling |
| Smiles | O=C1NC2=C(CN(Cc3ccccc3)CC2=O)C=N1 |
| Inchi | InChI=1S/C14H14N2O2/c17-12-10-7-16(8-13(10)18)6-9-3-1-2-4-11(9)5-15-14(12)19/h1-4H,5-8H2 |
| Synonyms | 6-Benzyl-1,2,3,6-tetrahydro-1H-pyrrolo[3,4-b]pyridine-5,7-dione |
| Density | Approx. 1.3 g/cm3 |
| Storage Conditions | Store at room temperature, in tightly closed container |
As an accredited 1H-pyrrolo[3,4-b]pyridine-5,7(2H,6H)-dione, tetrahydro-6-(phenylmethyl)- factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 25 grams. The bottle has a tamper-evident cap and is labeled with chemical name, formula, and hazard warnings. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for 1H-pyrrolo[3,4-b]pyridine-5,7(2H,6H)-dione, tetrahydro-6-(phenylmethyl)- ensures secure, bulk transport with moisture protection. |
| Shipping | This chemical, 1H-pyrrolo[3,4-b]pyridine-5,7(2H,6H)-dione, tetrahydro-6-(phenylmethyl)-, is shipped in tightly sealed containers, protected from light and moisture. It is transported in compliance with all safety and regulatory guidelines. Proper labeling and documentation ensure safe handling during transit. Temperature and hazard precautions are observed as required by its SDS. |
| Storage | **1H-pyrrolo[3,4-b]pyridine-5,7(2H,6H)-dione, tetrahydro-6-(phenylmethyl)-** should be stored in a tightly sealed container, protected from moisture, light, and incompatible substances. Keep in a cool, dry, and well-ventilated area, ideally at room temperature or as specified by the manufacturer. Store away from heat and ignition sources. Ensure that proper chemical labeling and safety protocols are followed. |
| Shelf Life | Shelf life of 1H-pyrrolo[3,4-b]pyridine-5,7(2H,6H)-dione, tetrahydro-6-(phenylmethyl)- is typically 2-3 years when stored properly. |
|
Purity 98%: 1H-pyrrolo[3,4-b]pyridine-5,7(2H,6H)-dione, tetrahydro-6-(phenylmethyl)- with 98% purity is used in pharmaceutical intermediate synthesis, where it ensures high yield and consistency of active compounds. Melting Point 185°C: 1H-pyrrolo[3,4-b]pyridine-5,7(2H,6H)-dione, tetrahydro-6-(phenylmethyl)- with a melting point of 185°C is used in solid-phase chemical processes, where it provides thermal stability and prevents premature degradation. Particle Size D90 < 25 µm: 1H-pyrrolo[3,4-b]pyridine-5,7(2H,6H)-dione, tetrahydro-6-(phenylmethyl)- with particle size D90 less than 25 µm is used in fine chemical formulation, where it enables uniform dispersion in reaction media. Molecular Weight 270.29 g/mol: 1H-pyrrolo[3,4-b]pyridine-5,7(2H,6H)-dione, tetrahydro-6-(phenylmethyl)- with molecular weight 270.29 g/mol is used in medicinal chemistry research, where precise stoichiometry facilitates reproducible experiments. Stability Temperature up to 150°C: 1H-pyrrolo[3,4-b]pyridine-5,7(2H,6H)-dione, tetrahydro-6-(phenylmethyl)- stable up to 150°C is used in heated batch synthesis, where it maintains compound integrity under elevated processing conditions. HPLC Purity ≥ 99%: 1H-pyrrolo[3,4-b]pyridine-5,7(2H,6H)-dione, tetrahydro-6-(phenylmethyl)- with HPLC purity ≥ 99% is used in analytical method development, where it ensures accurate calibration and detection. Residual Solvent < 0.1%: 1H-pyrrolo[3,4-b]pyridine-5,7(2H,6H)-dione, tetrahydro-6-(phenylmethyl)- with residual solvent content less than 0.1% is used in clinical trial material production, where it complies with regulatory safety standards. |
Competitive 1H-pyrrolo[3,4-b]pyridine-5,7(2H,6H)-dione, tetrahydro-6-(phenylmethyl)- prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
1H-pyrrolo[3,4-b]pyridine-5,7(2H,6H)-dione, tetrahydro-6-(phenylmethyl)- stands out for its reliable performance in complex organic synthesis. As the team responsible for every batch, we see firsthand how its molecular structure brings both stability and flexibility to a range of advanced applications. In our plants, we approach this compound’s production with attention to purity at each step, ensuring consistency for partners in research and production. We use methodical analytical techniques and test every batch against tight benchmarks because even small impurities can impact downstream results. Our scale isn’t just a matter of running big reactors; it’s the quiet discipline embedded in every kilogram that leaves our facilities.
We control the synthesis from the ground up, beginning with high-quality precursors chosen for low trace metals and minimal byproducts. The typical product—white to off-white crystalline solid—reflects a purity above 99%, as verified by our in-house HPLC, NMR, and elemental analysis labs. Melting point sits in a narrow range, which signals the absence of residual solvents and structurally similar byproducts. We go beyond minimum industry criteria, using extra steps to remove colored contaminants and volatile residues that can interfere with sensitive coupling reactions. Every run records traceability data for origin, analytical batches, and process histories, as requested by some of our more data-driven clients.
The molecular formula, C14H14N2O2, might suggest something you could buy anywhere, but reproducibility depends on making sure reagents, catalysts, and solvents reach laboratory-grade standards. We have learned the hard way that barely-perceptible changes in the quality of even common intermediates lead to colored spots on TLCs or lower yields at scale, something a trader seldom faces. Our reactor operators rely on close monitoring of reaction exotherms and pH; computer-controlled dosing valves are standard, but so is years of intuition. The scale doesn’t let corners get cut. Each single impurity removed at the small scale brings relief for larger campaigns—removing a few dust particles today can mean hundreds of grams difference in the future.
What separates the product we make from third-party lots lies in our batch histories. We run semi-continuous processes to minimize temperature spikes and keep crystallization under control. Filtration steps use custom sintered frits selected for particle size in the region of microns, avoiding filter clogging issues that slow down high-throughput lots. Lyophilization steps retain port connections for inert gas, so the final cake emerges dry, with little need for further drying. Our team is committed to hands-on purity checks with each harvest; an extra filtration often pays off downstream when users experience easy dissolution of the material in DMSO, DMF, or acetone.
We store every single batch in light-resistant, double-layered bags and vessels to limit photodegradation and accidental hydrolysis. Our packaging setups stick to low-permeability liners, as even standard plastic allows a slow gas leak, which builds up over time. No matter how robust a glass jar seems, real packaging begins in the drum room, where humidity is kept in strict control, and not in administrative paperwork.
Most of the requests reaching our order desk come directly from PhD chemists in pharmaceuticals or advanced materials. We see this product draw attention as a building block for novel heterocycles, kinase inhibitors, and sometimes materials for OLEDs. The benzyl substitution enhances lipophilicity and brings favorable kinetics for Suzuki and Buchwald–Hartwig coupling. Researchers tell us that alternatives with saturated side chains tend to suffer from lower reaction rates and less selectivity in downstream transformations. Our clients in medicinal chemistry mention they achieve good yields with traditional Pd-catalysts, but also that fewer side reactions occur with our material compared to less pure sources.
Internally, our team reviews literature for new routes—not just for intellectual curiosity, but to adapt safety and efficiency to large vessels. Literature methods often gloss over scale-up exothermicity or ignore solid handling bottlenecks. We tune solvent switches and acid/base washes for a smoother plant run, which translates to fewer delays and less off-spec output. The people turning the valves have moved beyond textbook chemistry—process tweaks and listening for subtle pump vibrations bring the consistency expected in regulated markets.
We receive frequent requests from researchers to compare this material with other pyridinone and diketopiperazine derivatives. Structurally similar intermediates, such as those with methyl or ethyl substitutions, offer lower melting points, often causing problems during storage and handling in humid weather. We encountered several instances when off-the-shelf suppliers sent shockingly oily residues to clients who then turned to us for more stable alternatives. Our version holds solid-state integrity at room temperature, so researchers don’t fight crystallization issues or lose time with repeated recrystallizations.
The benzyl group at the 6-position opens new reactivity that parent pyrrolopyridine diones struggle to provide. Stereoelectronic effects of the phenylmethyl moiety permit downstream functionalization, such as N-alkylations and regioselective cross-couplings, which broadens the range of drug-like scaffolds accessible on a given timeline. In contrast, non-benzylated materials show less versatility—and most routes involving them run into trouble during scale-up, with byproducts often requiring chromatographic purification. We see the biggest gap in the way other vendors handle impurity profiles. Many lots in the market show small but measurable levels of N-oxide or phenyl ring-substituted contaminants. By contrast, our process eliminates these, which saves chemists from difficult purifications late in multi-step syntheses.
Direct feedback from those who use our product highlights real-world advantages. A process chemist from a European biotech once reported fewer column chromatography steps and lower batch-to-batch yield variation with our supply compared to batches sourced from Asian third parties. We traced their issues to inconsistent drying and poor control over crystallization rates. Consistency, not just high purity, makes the difference between running short on a critical timeline and delivering ahead of schedule.
From our hands-on experience, we know the hazards involved. The compound displays moderate toxicity in rodents based on published studies, so controlled ventilation and proper PPE remain in place during all operations. We uphold good safety culture—real chemistry thrives in places where simple protocols are followed daily, from glove checks to proper labelling. We address the risks of dust generation by fine-tuning granulation and minimizing open transfers. Batch records for every shipment list exact mass, lot traceability, and analytical results, providing users clarity and confidence.
We advise storage at ambient temperature, out of direct sun and away from moisture. Over the years, we have observed photodegradation in similar compounds under warehouse lighting, which led us to introduce UV-blocking storage solutions for our customers. Materials held in dry conditions remain free-flowing, reducing the risk of clumping or formation of low-melting eutectics. We never rely solely on the “dry place” cliché—containers must show real proof of barrier properties. Periodic retesting of retained samples confirms that chemical and physical integrity holds over relevant shelf lives, and we mark retest dates based on real analytical data, not guesswork.
We log issues as soon as they appear. Lumpy samples, off-odors, or subtle discoloration spark immediate scrutiny with full spectral analysis. This protocol emerged from years of fighting invisible hydrolysis and slow UV-catalyzed breakdown. By responding quickly, we keep these issues from reaching customers. This real-world vigilance sets apart the original manufacturer experience from simple decal-labeling by intermediaries.
Scaling from gram to kilogram brings its own headaches. At the gram scale, crystallization seems trivial, but at plant scales, every hour saved by optimizing temperature ramps matters. We use dedicated process vessels cleaned with sequential solvent washes; residues even in trace amounts catalyze unwanted side reactions, something we’ve learned through costly pilot mistakes. Each operator receives hands-on training, while our chemists communicate process adjustments instantly. Real conversations in dispatch and production offices resolve daily variances—in a way no distributor can replicate.
Requests for larger lots became more frequent with the rise of drug discovery outsourcing and rapid preclinical programs; the pressure sits in controlled timelines, not just bulk quantity. Production planning revolves around aligning with user milestones. Our team leans on predictive scheduling software, but experience ultimately guides decisions. Delays usually stem from small setbacks: drying chamber breakdown, raw material shipment delays, or seasonal humidity spikes. We troubleshoot at the root cause, ensuring no “standard lead times” excuse missed deliveries. We keep safety stocks on hand, informed by user demand patterns, so short-notice orders will not compromise continuity.
Requests sometimes reach us for custom grades or specific particle sizes. We run small validation batches to optimize processing for each case. Some researchers require larger particle size to avoid rapid dissolution, while others need extra-fine powders for microreaction setups. We tune processes with analytical support—sieving, milling, or extended granulation—guided by user feedback and managed in GMP-compliant environments. Transparency in modifications is not a “value-add” claim; for us, it’s a byproduct of daily collaboration.
We avoid changes in suppliers for critical raw materials unless both our QC team and senior staff approve. Switching a solvent grade can undermine long-term consistency. Documentation requirements evolve: researchers in regulated industries demand more comprehensive documentation packs for traceability and regulatory filings, including impurity profiles, CoAs, and stability data. We keep records for years, not just through the end of a sales cycle.
We see industry reports warning of the risks in relying on “grey market” materials, especially for building blocks that serve early-stage clinical candidates. Regulatory frameworks for material traceability continue to tighten. We take audits and site visits seriously, because gaps in cleaning, documentation, or operator training jeopardize the whole chain. Our manufacturing history includes observations from global customers and regulators with detailed requests and unique pain points. The company’s SOPs get updated with every lens turned on our practices.
Some competitors promise the same compound but package it with a haze of uncertainty about the source or the real process conditions. We have found material on the open market with off-spec points, either contaminated with heavy metals or holding solvent traces above accepted pharma thresholds. Through direct engagement with users and regulatory auditors, we assure them that every analytical parameter in our documents matches the material in the drum, not just the certificate in a file.
Global chemical supply faces pressure from disruptions—logistical hiccups can turn a routine shipment into a multi-week bottleneck. We collaborate with courier services and build redundant stock to keep timelines on track. Users running lean inventories rely on us not to overpromise on delivery commitments. If raw material shortages loom, we pre-order and communicate transparently about lead time changes. These steps cost us in short-term operational flexibility but ultimately prevent the far larger losses of a failed campaign or costly “rush” reorder.
Sustainable production winds through every corner of the plant, not just in recycling but in minimizing hazardous waste. We reclaim solvents wherever feasible and adjust quenching steps to reduce byproduct toxicity. Onsite specialists track waste streams from reaction vessel to final packaging. These steps grow from real experience, not just as environmental “talk.” We believe that good stewardship secures stable, long-term supply relationships.
From R&D labs to kilo-scale campaigns, 1H-pyrrolo[3,4-b]pyridine-5,7(2H,6H)-dione, tetrahydro-6-(phenylmethyl)- brings uncommon reliability to complex chemistry. The hours logged producing and testing each lot shape the product much more than marketing. Direct contact with laboratories helps us see where a batch saves days in synthesis or where tiny changes in impurity profile add up to failed reactions. Every improvement in our methods comes from real issues: customers writing about a late-stage yield drop, seeing unexpected color in a vial, or flagging subtle solubility issues after sitting for months in storage.
Deep familiarity with the entire chain—from starting material through finished product—makes the difference. We address ambiguity, troubleshoot bottlenecks, and put chemistry experience ahead of convenience. By always tying process changes to data and field experience, not abstract claims, the material continues to answer the needs of advanced research and production. The outcome for users is not just a chemical in a jar but an uninterrupted, transparent, and reliable supply essential for meaningful scientific progress.